Gilead is expecting to get $1.9 billion dollars in sales by 2029 with this experimental drug(liver therapy drug). So the question is, how much would Gilead would expect to make in sales from Biotron if the compound turns out to be amazing?
- Forums
- ASX - By Stock
- BIT
- BIT036- a likely candidate for curing COVID-19
BIT036- a likely candidate for curing COVID-19, page-1925
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.91M |
Open | High | Low | Value | Volume |
5.2¢ | 5.2¢ | 5.2¢ | $5.2K | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18564 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 57267 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18564 | 0.052 |
6 | 93870 | 0.051 |
8 | 337005 | 0.050 |
3 | 698893 | 0.049 |
1 | 100000 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 57267 | 1 |
0.057 | 46602 | 2 |
0.058 | 71186 | 2 |
0.059 | 57500 | 2 |
0.060 | 20000 | 2 |
Last trade - 10.00am 22/05/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online